Feeds

Sony pumps cash into gene-wrangling joint venture

Electronics outfit thinks the future is wetware and wants in before the rush

Remote control for virtualized desktops

PlayStation purveyor Sony wants to be remembered for more than overpriced electronics and massive data breaches, having just launched a joint venture in the field of genome research.

The electronics giant has teamed up with medical firm M3, in which Sony is already the majority investor, and US biz Illumina, which makes genome-sequencing gear.

The new venture, named P5, will build a “genome information platform” business to sell genome analysis services to research institutions and enterprises in Japan, according to Sony.

It’s also interested in combining genome data with other medical data to support advancements in personalised healthcare, a field imagined to one day offer medical treatments optimised for individuals.

“We aim to facilitate genome research that further advances Japanese medical care, and in the future establish a new service platform for the medical industry," said Tadashi Saito, head of Sony’s medical biz, in a canned statement.

M3 director Itaru Tanimaru was even bolder, claiming that gene diagnosis and treatment could have a greater impact on lives than the internet.

“The current status of the human genome industry is comparable to the internet in the early 1990's, when companies such as Google, Amazon and Facebook had yet to emerge,” he added.

“Going forward, I expect companies and services of this magnitude to also appear in this industry. This three party alliance combines each company's unique strengths and resources, and together we intend to build a service platform that could not have been realised by others.”

Sony CEO Kazuo Hirai has already shown he intends to make the firm’s medical business a major part of its future.

Back in 2012 it invested ¥50bn ($642m) to take a ten per cent stake in ailing digital camera company Olympus, with which it plans to develop new medical equipment. ®

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
I'll be back (and forward): Hollywood's time travel tribulations
Quick, call the Time Cops to sort out this paradox!
Musicians sue UK.gov over 'zero pay' copyright fix
Everyone else in Europe compensates us - why can't you?
Megaupload overlord Kim Dotcom: The US HAS RADICALISED ME!
Now my lawyers have bailed 'cos I'm 'OFFICIALLY' BROKE
MI6 oversight report on Lee Rigby murder: US web giants offer 'safe haven for TERRORISM'
PM urged to 'prioritise issue' after Facebook hindsight find
BT said to have pulled patent-infringing boxes from DSL network
Take your license demand and stick it in your ASSIA
Right to be forgotten should apply to Google.com too: EU
And hey - no need to tell the website you've de-listed. That'll make it easier ...
prev story

Whitepapers

Go beyond APM with real-time IT operations analytics
How IT operations teams can harness the wealth of wire data already flowing through their environment for real-time operational intelligence.
Why CIOs should rethink endpoint data protection in the age of mobility
Assessing trends in data protection, specifically with respect to mobile devices, BYOD, and remote employees.
A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Protecting against web application threats using SSL
SSL encryption can protect server‐to‐server communications, client devices, cloud resources, and other endpoints in order to help prevent the risk of data loss and losing customer trust.